Page last updated: 2024-08-26

becatecarin and Chemical and Drug Induced Liver Injury

becatecarin has been researched along with Chemical and Drug Induced Liver Injury in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamson, PC; Bernstein, M; Blaney, SM; Chen, Z; Ivy, P; Kuhn, JG; Langevin, AM; Sun, J1

Trials

1 trial(s) available for becatecarin and Chemical and Drug Induced Liver Injury

ArticleYear
A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:3

    Topics: Adolescent; Adult; Aminoglycosides; Antibiotics, Antineoplastic; Bone Marrow Diseases; Carbazoles; Central Nervous System Neoplasms; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Female; Glucosides; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Neoplasm Proteins; Neoplasms; Pancreatitis; Rhabdomyosarcoma; Salvage Therapy; Topoisomerase II Inhibitors

2008